drugset / Trial / NCT00717990
Irinotecan, Capecitabine and Avastin for Metastatic Colorectal Cancer as Salvage Treatment
NaSingle-groupOpen-labelTreatment
Summary
This study will evaluate the efficacy of Irinotecan,Capecitabine and Avastin combination in patients with no response to previous treatment with 5-Fluorouracil,Leucovorin,Eloxatin and Avastin.
Timeline
- Start
- 2008-04
- Primary completion
- 2012-12
- Completion
- 2012-12
Outcome
Outcome not reported
Stopped (Enrollment): “Poor Accrual”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | 7.5 mg/kg | Intravenous |
| Subject | Capecitabine | Small molecule | 2000 mg/m2 | Oral |
| Subject | Irinotecan | Small molecule | 250 mg/m2 | Intravenous |